MedTrace Logo

Trial With Deltex Cardio in Elective Bowel Resection Patients

NCT01244685 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2012-10-05

No results posted yet for this study

Summary

The purpose of this study is:

* To determine if the intraoperative fluid administration with the Deltex CardioQ esophageal Doppler will reduce the length of stay after elective bowel resection.
* The probe can be used to dynamically measure stroke volume and cardiac output. This information will assist us in determining the ideal amount of fluids to be administered.
* To determine if the fluid administration established by the esophageal probe will result in a shorter length of stay in elective bowel resection patients.
* The investigators plan to enroll 100 patients in this study.

Conditions

  • 1 Fluid Management

Interventions

DEVICE

Deltex CardioQ Probe

Deltex CardioQ probe will be placed nasally in the operating room by the anesthesia team and fluid management will be administered via anesthesia protocol.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01244685 on ClinicalTrials.gov